Acid-Associated Heartburn Symptoms and Dose of Esomeprazole
Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
This is a multi-center, double-blind, parallel-group, randomized, proof of concept trial to
investigate the relationship between dose of esomeprazole magnesium and acid-associated
heartburn symptoms during 4 weeks of treatment. The safety and tolerability of esomeprazole
magnesium in doses up to 40 mg BID will also be assessed.